688163.SHG Shanghai Serum Bio-Technology Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
30.65 CNY
Close of Nov 4, 2026
20.98 52.70
Market cap
CNY 3.32B
P/E
62.6x
P/B
2.78x
ROE
7.4%
Dividend yield
1.04%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688163.SHG undervalued?

Graham number
Price30.65
Graham value11.02
Premium178.2%

688163.SHG trades 178.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Serum Bio-Technology Co. Ltd. A fundamental analysis

No fundamental analysis for Shanghai Serum Bio-Technology Co. Ltd. A yet.

Shanghai Serum Bio-Technology Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Serum Bio-Technology Co. Ltd. A

Shanghai Serum Bio-Technology Co., Ltd. engages in research, development, production, operation, and sales of antitoxin and antivenom serum products for biotoxins and biosafety in China. It offers equine anti-tetanus immunoglobulin, antivenom, and anti-rabies serum products. The company also engaged in the collection and sale of animal immune plasma. The company was founded in 1999 and is based in Shanghai, China.

Full company profile